Singapore: Demonstrating its commitment to clinical trial transparency, multinational pharmaceutical company GlaxoSmithK...
Singapore: Taiwan's PharmaEngine appointed Dr Alain Herrera as senior advisor for clinical strategy, operations, corpora...
Singapore: A team of American and Chinese neuroscientists at the Cold Spring Harbor Laboratory (CSHL) have carried out r...
Singapore: Japan's Chugai Pharmabody Research (CPR) has started its operations in Singapore. The company started operati...
Singapore: Helmedix, an early stage biopharmaceutical company developing novel therapies for autoimmune and inflammatory...
Singapore: Japan-headquartered global firm, Takeda Pharmaceutical, appointed Mr François-Xavier Roger as its chief fi...
Singapore: Novartis entered into an exclusive global licensing and research collaboration agreement with Regenerex, a bi...
Singapore: The shareholders of Boehringer Ingelheim have appointed Dr Joachim Hasenmaier to Boehringer Ingelheim's board...
Singapore: China Health Resource (CHRI) has developed a revolutionary TCM migraine medication called Toufeng Migraine ta...
Singapore: Alcon, the global leader in eye care and a division of Novartis, has received European Commission's approval ...
Singapore: Australia's QRxPharma has received Complete Response Letter (CRL) from USFDA for its MOXDUO New Drug Applicat...
Singapore: Gilead Sciences has recieved European Commission marketing authorization approval for once-daily Tybost (cobi...
Singapore: Merck and AstraZeneca entered into a licensing agreement for Merck's oral small molecule inhibitor of WEE1 ki...
Singapore: Scientists at the Department of Pharmacy and Pharmacology, University of Bath, UK, demonstrated that anti-inf...
Australia has a long history in biomedical research, with a reputation for excellence and invention since the early 1900...
Singapore: HUYA Bioscience, a leader in globalizing China's biopharmaceutical innovations, has signed a strategic partne...
Singapore: European Commission has granted an additional indication for GlaxoSmithKline's Tyverb (lapatinib) to be used ...
Singapore: Japanese company Astellas Pharma has completed patient recruitment for the isavuconazole phase III registrati...
